Massachusetts General Hospital develops AI model that predicts patient's 12-year lung cancer risk 

Boston-based Massachusetts General Hospital researchers created an automated deep learning model that can predict a patient's likelihood of developing lung cancer within the next 12 years, according to a Sept. 1 study published in the Annals of Internal Medicine.

To develop the artificial intelligence-based approach, the research team used chest radiograph images and patient demographic data including age, sex and current smoking status that is available in EHRs. The model makes predictions based on chest X-ray images from more than 41,000 people that participated in a multicenter trial of lung cancer screening with chest X-rays, called the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 

Researchers validated the final model in 5,615 additional trial participants and 5,493 individuals involved from a second trial, the National Lung Screening Trial. The deep learning model outperformed the standard Medicare lung cancer screening criteria, which is the current clinical standard, and missed 30.7 percent fewer lung cancers while screening the same number of individuals.

More articles on artificial intelligence:
Penn State develops algorithm to alert users of illegitimate medications online
Penn Medicine AI assists global consortium's COVID-19 data model: 4 notes
Defense Health Agency launches AI project for cancer detection

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.